Background illustration for clinical trials search

Paid Clinical Trials Chesapeake

Discover 382 paid clinical trials in Chesapeake, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for
Pleuropulmonary Blastoma
Location: Norfolk VA, Charlottesville VA, Washington D.C. DC,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06647953

Phase 3, Recruiting
Active & Responsive

Pediatric Post-Approval Registry

for
Obstructive Sleep Apnea
Location: Norfolk VA, Durham NC, Philadelphia PA, Sewickley PA,
Sponsor: Inspire Medical Systems, Inc.

Sex: All

Age: 18 - 21

Code: NCT04457154

Recruiting
Active & Responsive

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

for
Hyperphosphatemia,
Location: Norfolk VA, Ridgewood NY, Orange CT, Middlebury CT,
Sponsor: R1 Therapeutics

Sex: All

Age: 18+

Code: NCT06712654

Phase 2, Recruiting
Active & Responsive

A Study of TAK-360 in Adults With Idiopathic Hypersomnia

for
Idiopathic Hypersomnia
Location: Norfolk VA, Huntersville NC, Denver NC, Columbia SC,
Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06812078

Phase 2, Recruiting
Active & Responsive

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis (AD)
Location: Norfolk VA, Wilmington NC, Camp Hill PA, New York NY,
Sponsor: Enveda Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07298395

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

for
Plaque Psoriasis
Location: Norfolk VA, Rockville MD, New York NY, Cromwell CT,
Sponsor: Oruka Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07449702

Phase 2, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Norfolk VA, Richmond VA, Morehead City NC, Raleigh NC,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Norfolk VA, Richmond VA, New Bern NC, Morehead City NC,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase 3, Recruiting
Active & Responsive

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

for
Diabetic Peripheral Neuropathic Pain
Location: Norfolk VA, Morehead City NC, Washington D.C. DC,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07231419

Phase 3, Recruiting
Active & Responsive

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events

for
Cardiovascular Disease
Location: Norfolk VA, Midlothian VA, Kinston NC, Bowie MD,
Sponsor: Amgen

Sex: All

Age: 50 - 70+

Code: NCT07136012

Phase 3, Recruiting
Active & Responsive

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

for
Obesity, Overweight
Location: Norfolk VA, Hyattsville MD, Baltimore MD, Monroe NC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07321886

Phase 3, Recruiting
Active & Responsive

Study of ALK-001 on the Progression of Stargardt Disease

for
Stargardt Disease
Location: Norfolk VA, Fairfax VA, Pittsburgh PA, Erie PA,
Sponsor: Alkeus Pharmaceuticals, Inc.

Sex: All

Age: 8 - 45

Code: NCT07419334

Phase 3, Recruiting
Active & Responsive

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

for
Non-segmental Vitiligo
Location: Norfolk VA, Rockville MD, The Bronx NY, Mississauga,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07431177

Phase 2, Recruiting
Active & Responsive

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

for
Healthy
Location: Norfolk VA, Richmond VA, Falls Church VA, Durham NC,
Sponsor: Pfizer

Sex: All

Age: 0 - 49

Code: NCT07160244

Phase 3, Recruiting
Active & Responsive

Phase 1 Study of Intravaginal KB15A

for
Healthy Subjects
Location: Norfolk VA
Sponsor: ZabBio Inc.

Sex: Female

Age: 18 - 45

Code: NCT07222020

Phase 1, Recruiting
Active & Responsive

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

for
Lichen Planopilaris
Location: Norfolk VA, Richmond VA, Durham NC, Roanoke VA,
Sponsor: Priovant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07532603

Phase 2, Phase 3, Recruiting
Active & Responsive

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Virginia Beach VA, Raleigh NC, Burke VA,
Sponsor: Expedition Therapeutics, Inc

Sex: All

Age: 40 - 70+

Code: NCT07684820

Phase 2, Recruiting
Active & Responsive

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

for
Primary Sjogren's Disease
Location: Chesapeake VA, Durham NC, Rockville MD, Philadelphia PA,
Sponsor: Vor Biopharma

Sex: All

Age: 18 - 70+

Code: NCT07404865

Phase 3, Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

for
Rheumatoid Arthritis
Location: Chesapeake VA, Duncansville PA, The Bronx NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07137598

Phase 2, Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

for
Triple Negative Breast Neoplasms
Location: Norfolk VA, Clinton MD, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06841354

Phase 3, Recruiting